Puma Biotechnology (PBYI) Cash from Operations (QoQ) (2011 - 2026)
Puma Biotechnology (PBYI) Cash from Operations (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Puma Biotechnology | 408.29 Mn | 370.00 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.91% |
| Dec 31, 2025 | 48.82% |
| Sep 30, 2025 | -31.20% |
| Jun 30, 2025 | 289.87% |
| Mar 31, 2025 | -76.86% |
| Dec 31, 2024 | 41.39% |
| Sep 30, 2024 | 974.78% |
| Jun 30, 2024 | -90.87% |
| Mar 31, 2024 | 7.57% |
| Dec 31, 2023 | -1.51% |
| Sep 30, 2023 | 222.06% |
| Jun 30, 2023 | 24.71% |
| Mar 31, 2023 | -65.60% |
| Dec 31, 2022 | -55.48% |
| Sep 30, 2022 | 224.40% |
| Jun 30, 2022 | 48.41% |
| Mar 31, 2022 | -394.85% |
| Dec 31, 2021 | -151.77% |
| Sep 30, 2021 | 14,286.49% |
| Jun 30, 2021 | -100.47% |